DEPLOYDatabase

Robot model

Sentire

Endoscopic surgical robotic system CE-marked under EU MDR in May 2026, covering general surgery, gynecology, thoracic, and urology.

Form factor
surgical
Maturity
pilot
Lifecycle
active
Deployments
2

The verified answer

As of Aug 2026, DEPLOY verifies Sentire, a surgical by Cornerstone Robotics (pilot): 2 verified deployments on record. 1 source back the record.

Overview

Endoscopic surgical robotic system CE-marked under EU MDR in May 2026, covering general surgery, gynecology, thoracic, and urology. Clinical investigation ongoing at Portsmouth Hospitals NHS Trust; no FDA 510(k) filed for U.S. market.

Verified vs. claimed

Maturity stage
pilot(Small-scale deployment in controlled or trial conditions.)
Sources on file
View all sources →

Key facts

Clearance

EU CE Mark MDR + Singapore HSA (May 2026)

Specialties

General surgery, gynecology, thoracic, urology

Data & sources

Web sources

1

1 source backing this record.View all →

Pricing

No verified price is on record for Sentire. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

Deployments (2)

  • Cornerstone Robotics, Hong Kong-based surgical robotics innovator, presenting at 2nd Global Health Summit 2026.

  • Cornerstone Robotics 100th surgical robot rolled off Shenzhen production line in 2025.

Free to use on your site, with a link back to DEPLOY.

Sentire on the deployment map

View the global map

Where Sentire is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for Sentire.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (1)

  1. https://www.prnewswire.com/news-releases/sentire-surgical-system-receives-ce-mark-mdr-approval-cornerstone-robotics-enters-a-new-era-in-its-global-expansion-302780965.html

Common questions

What is Sentire?
Endoscopic surgical robotic system CE-marked under EU MDR in May 2026, covering general surgery, gynecology, thoracic, and urology. Clinical investigation ongoing at Portsmouth Hospitals NHS Trust; no FDA 510(k) filed for U.S. market.
How much does Sentire cost?
Sentire's price is not publicly disclosed. DEPLOY has no verified price on record for Sentire from Cornerstone Robotics. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is Sentire actually deployed in the real world?
Yes. Sentire is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes Sentire?
Sentire is made by Cornerstone Robotics, based in Hong Kong, founded in 2019.
Where is Sentire deployed?
2 verified deployments of Sentire are on the DEPLOY registry, including at Hong Kong, Shenzhen.
Can you buy Sentire?
Sentire is in pilot deployments with named customers and is not yet broadly for sale.
What are alternatives to Sentire?
On the DEPLOY registry, comparable surgical robots to Sentire include Edison Histotripsy System, da Vinci (and Ion), Toumai, Stryker Mako SmartRobotics.
How does Sentire compare to Edison Histotripsy System?
Sentire and Edison Histotripsy System (HistoSonics · 14 deployments) are both surgical robots on the DEPLOY registry. Sentire has 2 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is Sentire a top surgical?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Sentire ranks in roughly the top 68% of surgical models tracked by the registry.
What is Sentire's maturity stage?
Sentire is at the pilot stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Pilot stage means at least one named-customer trial deployment is verified.
Is Sentire safe?
Sentire has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-07-12

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-07-12

Maturity + lifecycle

Maturity stage: pilot

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Sentire.

Recent coverage

Sentire in third-party press